Search

everythinglearnresearchcommunity

for

Search:↓

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Alopecia areata is an autoimmune disease with genetic links, treatable with certain medications, and can affect mental health.

Childhood Alopecia Areata causes hair loss and requires varied treatments, with psychological support being crucial.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

Myasthenia gravis can affect both motor and non-motor systems due to immune system issues.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

Regulatory T-cells are important for healing and regenerating tissues in various organs by controlling immune responses and aiding stem cells.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Increasing regulatory T cells may help treat alopecia areata by reducing autoimmunity and promoting hair growth.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Intestinal intraepithelial lymphocytes are crucial for gut immunity and maintaining the mucosal barrier.